-+ 0.00%
-+ 0.00%
-+ 0.00%

Atea Pharmaceuticals Completes Enrollment in Phase 3 HCV Trial of Bemnifosbuvir and Ruzasvir

路透·12/22/2025 12:00:43

登录查看新闻详情